Gene Expression of Abcc2 and Its Regulation by Chicken Xenobiotic Receptor

Overview

Journal Toxics

Date 2024 Jan 22

PMID 38251011

Authors

Yanhong Gao

Huacheng Deng

YuYing Zhao

Mei Li

Liping Wang

Yujuan Zhang

Affiliations

Soon will be listed here.

Abstract

Membrane transporter multidrug resistance-associated protein 2 (MRP2/Abcc2) exhibits high pharmaco-toxicological relevance because it exports multiple cytotoxic compounds from cells. However, no detailed information about the gene expression and regulation of MRP2 in chickens is yet available. Here, we sought to investigate the expression distribution of Abcc2 in different tissues of chicken and then determine whether Abcc2 expression is induced by chicken xenobiotic receptor (CXR). The bioinformatics analyses showed that MRP2 transporters have three transmembrane structural domains (MSDs) and two highly conserved nucleotide structural domains (NBDs), and a close evolutionary relationship with turkeys. Tissue distribution analysis indicated that Abcc2 was highly expressed in the liver, kidney, duodenum, and jejunum. When exposed to metyrapone (an agonist of CXR) and ketoconazole (an antagonist of CXR), Abcc2 expression was upregulated and downregulated correspondingly. We further confirmed that Abcc2 gene regulation is dependent on CXR, by overexpressing and interfering with CXR, respectively. We also demonstrated the induction of Abcc2 expression and the activity of ivermectin, with CXR being a likely mediator. Animal experiments demonstrated that metyrapone and ivermectin induced Abcc2 in the liver, kidney, and duodenum of chickens. Together, our study identified the gene expression of Abcc2 and its regulation by CXR in chickens, which may provide novel targets for the reasonable usage of veterinary drugs.

References

Borst P, Zelcer N, van de Wetering K . MRP2 and 3 in health and disease. Cancer Lett. 2006; 234(1):51-61. DOI: 10.1016/j.canlet.2005.05.051. View

Chen Z, Shi T, Zhang L, Zhu P, Deng M, Huang C . Mammalian drug efflux transporters of the ATP binding cassette (ABC) family in multidrug resistance: A review of the past decade. Cancer Lett. 2015; 370(1):153-64. DOI: 10.1016/j.canlet.2015.10.010. View

Mani S, Dou W, Redinbo M . PXR antagonists and implication in drug metabolism. Drug Metab Rev. 2013; 45(1):60-72. PMC: 3583015. DOI: 10.3109/03602532.2012.746363. View

Lee J, Chen H, Chen H, Ni Y, Hsu H, Chang M . Neonatal Dubin-Johnson syndrome: long-term follow-up and MRP2 mutations study. Pediatr Res. 2006; 59(4 Pt 1):584-9. DOI: 10.1203/01.pdr.0000203093.10908.bb. View

Liu X . Transporter-Mediated Drug-Drug Interactions and Their Significance. Adv Exp Med Biol. 2019; 1141:241-291. DOI: 10.1007/978-981-13-7647-4_5. View

Di Masi A, De Marinis E, Ascenzi P, Marino M . Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects. Mol Aspects Med. 2009; 30(5):297-343. DOI: 10.1016/j.mam.2009.04.002. View

Arana M, Tocchetti G, Rigalli J, Mottino A, Villanueva S . Physiological and pathophysiological factors affecting the expression and activity of the drug transporter MRP2 in intestine. Impact on its function as membrane barrier. Pharmacol Res. 2016; 109:32-44. DOI: 10.1016/j.phrs.2016.04.014. View

Brueck S, Bruckmueller H, Wegner D, Busch D, Martin P, Oswald S . Transcriptional and Post-Transcriptional Regulation of Duodenal P-Glycoprotein and MRP2 in Healthy Human Subjects after Chronic Treatment with Rifampin and Carbamazepine. Mol Pharm. 2019; 16(9):3823-3830. DOI: 10.1021/acs.molpharmaceut.9b00458. View

Karpale M, Hukkanen J, Hakkola J . Nuclear Receptor PXR in Drug-Induced Hypercholesterolemia. Cells. 2022; 11(3). PMC: 8833906. DOI: 10.3390/cells11030313. View

10.

He J, Nishida S, Xu M, Makishima M, Xie W . PXR prevents cholesterol gallstone disease by regulating biosynthesis and transport of bile salts. Gastroenterology. 2011; 140(7):2095-106. PMC: 3109201. DOI: 10.1053/j.gastro.2011.02.055. View

11.

Wen X, Joy M, Aleksunes L . In Vitro Transport Activity and Trafficking of MRP2/ABCC2 Polymorphic Variants. Pharm Res. 2017; 34(8):1637-1647. PMC: 5500460. DOI: 10.1007/s11095-017-2160-0. View

12.

Nies A, Keppler D . The apical conjugate efflux pump ABCC2 (MRP2). Pflugers Arch. 2006; 453(5):643-59. DOI: 10.1007/s00424-006-0109-y. View

13.

Xu Z, Li M, Lu W, Wang L, Zhang Y . Chicken xenobiotic receptor upregulates the BCRP/ABCG2 transporter. Poult Sci. 2022; 102(1):102278. PMC: 9673116. DOI: 10.1016/j.psj.2022.102278. View

14.

Handschin C, Podvinec M, Meyer U . CXR, a chicken xenobiotic-sensing orphan nuclear receptor, is related to both mammalian pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Proc Natl Acad Sci U S A. 2000; 97(20):10769-74. PMC: 27098. DOI: 10.1073/pnas.97.20.10769. View

15.

Jedlitschky G, Hoffmann U, Kroemer H . Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition. Expert Opin Drug Metab Toxicol. 2006; 2(3):351-66. DOI: 10.1517/17425255.2.3.351. View

16.

Jarvinen E, Deng F, Kidron H, Finel M . Efflux transport of estrogen glucuronides by human MRP2, MRP3, MRP4 and BCRP. J Steroid Biochem Mol Biol. 2017; 178:99-107. DOI: 10.1016/j.jsbmb.2017.11.007. View

17.

Holland I, Blight M . ABC-ATPases, adaptable energy generators fuelling transmembrane movement of a variety of molecules in organisms from bacteria to humans. J Mol Biol. 1999; 293(2):381-99. DOI: 10.1006/jmbi.1999.2993. View

18.

Mohammad I, He W, Yin L . Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Biomed Pharmacother. 2018; 100:335-348. DOI: 10.1016/j.biopha.2018.02.038. View

19.

Gupta S, Singh P, Ali V, Verma M . Role of membrane-embedded drug efflux ABC transporters in the cancer chemotherapy. Oncol Rev. 2020; 14(2):448. PMC: 7358983. DOI: 10.4081/oncol.2020.448. View

20.

Jarvinen E, Kidron H, Finel M . Human efflux transport of testosterone, epitestosterone and other androgen glucuronides. J Steroid Biochem Mol Biol. 2019; 197:105518. DOI: 10.1016/j.jsbmb.2019.105518. View